(Q53289387)

13 May 2018

title

B cells and macrophages in cancer: yin and yang. (English)

1 reference

13 May 2018

author

Alberto Mantovani

series ordinal

1

1 reference

13 May 2018

language of work or name

English

0 references

publication date

1 March 2011

1 reference

13 May 2018

published in

Nature Medicine

1 reference

13 May 2018

volume

17

1 reference

13 May 2018

issue

3

1 reference

13 May 2018

page(s)

285-286

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1038/nm0311-285

exact match

0 references

cites work

Cancer-related inflammation

1 reference

https://api.crossref.org/works/10.1038%2FNM0311-285

Tumour-educated macrophages promote tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0311-285

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0311-285

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0311-285

FcRgamma activation regulates inflammation-associated squamous carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0311-285

Modulation of the antitumor immune response by complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0311-285

Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0311-285

CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0311-285

Macrophage polarization to a unique phenotype driven by B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0311-285

B-cell-derived lymphotoxin promotes castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0311-285

The CCL3 family of chemokines and innate immunity cooperate in vivo in the eradication of an established lymphoma xenograft by rituximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0311-285

M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0311-285

Immunological and inflammatory functions of the interleukin-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0311-285

Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0311-285

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NM0311-285

1 reference

13 May 2018

1 reference

13 May 2018